We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.AuthorsGeusens, P P; Truitt, K; Sfikakis, P; Zhao, P L; DeTora, L; Shingo, S; Lau, C S; Kalla, A; Tate, GAbstractTo evaluate the efficacy and tolerability of rofecoxib 25 mg and 50 mg once daily versus placebo and naproxen 500 mg twice daily in patients with RA.PublicationScandinavian journal of rheumatology, 2002, Vol 31, Issue 4, p230ISSN0300-9742Publication typeJournal ArticleDOI10.1080/030097402320318431